STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
1
13F, latest reported quarter
1895 Bancorp of Wisconsin insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for 1895 Bancorp of Wisconsin, Inc. /MD/ in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on May 31, 2024.
+21.8% median (+22.1% mean) 90-day return after 3 previous buys.
The trade is 0.3% of the 1,100 shares held after it.
1 other insider bought within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Harris Clarence bought about $22 of BCOW on Jun 6, 2024; 1 other insider bought within 30 days and 1 fund added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 30, 2024.
+21.5% median (+21.5% mean) 90-day return after 2 previous buys.
The trade is 8.8% of the 1,097 shares held after it.
1 other insider bought within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Harris Clarence bought about $708 of BCOW on May 31, 2024; 1 other insider bought within 30 days and 1 fund added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 85 shares held after it.
1 other insider bought within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hill Kristina bought about $624 of BCOW on May 31, 2024; 1 other insider bought within 30 days and 1 fund added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 77.9% of the 385 shares held after it.
1 other insider bought within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hill Kristina bought about $2.2K of BCOW on May 31, 2024; 1 other insider bought within 30 days and 1 fund added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 74.1% of the 1,485 shares held after it.
1 other insider bought within 30 days.
1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hill Kristina bought about $8.2K of BCOW on May 31, 2024, the largest insider purchase at the company since 2021; 1 other insider bought within 30 days and 1 fund added in the latest 13F quarter.
33 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-4.6%
TTM net income over average of 2023-09-30 and 2024-09-30
Return on equity BCOW
FY Dec 2023
-9.2%
FY Dec 2022
-0.2%
FY Dec 2021
+0.1%
FY Dec 2020
+2.2%
Sep 2024
-4.6%
Jun 2024
-9.3%
Mar 2024
-9.1%
Dec 2023
-9.2%
Sep 2023
-6.1%
Jun 2023
-0.9%
Mar 2023
-0.6%
Dec 2022
-0.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-0.6%
TTM net income over average of 2023-09-30 and 2024-09-30
Return on assets BCOW
FY Dec 2023
-1.2%
FY Dec 2022
-0.0%
FY Dec 2021
+0.0%
FY Dec 2020
+0.3%
Sep 2024
-0.6%
Jun 2024
-1.2%
Mar 2024
-1.2%
Dec 2023
-1.2%
Sep 2023
-0.8%
Jun 2023
-0.1%
Mar 2023
-0.1%
Dec 2022
-0.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
366.33x
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing BCOW
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Risk and compliance
100
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
5 not measured: Financial health, Growth, Insider conviction, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.